Carregant...

The PARAGON-HF trial: the sacubitril/valsartan in heart failure with preserved ejection fraction

Heart failure (HF) with preserved ejection fraction (HFpEF) is a clinical condition characterized by large pathophysiology heterogeneity with lack of effective therapies as proven by the disappointing results generated by randomized controlled trials. The innovative therapeutic concept provided by s...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Eur Heart J Suppl
Autors principals: Gronda, Edoardo, Vanoli, Emilio, Iacoviello, Massimo
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2020
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7944492/
https://ncbi.nlm.nih.gov/pubmed/33727901
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/eurheartj/suaa140
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!